SCHEMBL4332211

SCHEMBL4332211

CC(Cc1cccc(OCCOc2ccc(Cl)cc2Cl)c1)C(=O)O

nearest known ligand 0.53

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
PPARA Q07869 4/20 0.53
PPARD Q03181 2/20 0.53
MRGPRX4 Q96LA9 3/20 0.49
HPGD P15428 5/20 0.48
NLRP1 Q9C000 1/20 0.48
MAPT P10636 3/20 0.46
PPARG P37231 2/20 0.46
TDP1 Q9NUW8 3/20 0.46
SMN1; SMN2 Q16637 3/20 0.45
TSHR P16473 3/20 0.45
NPC1 O15118 2/20 0.44
ALDH1A1 P00352 2/20 0.44
RAB9A P51151 2/20 0.44
L3MBTL1 Q9Y468 2/20 0.44
HTT P42858 1/20 0.44
MDM2 Q00987 1/20 0.44
GPR55 Q9Y2T6 1/20 0.44
FFAR1 O14842 1/20 0.44
LMNA P02545 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4336847 0.88 PPARA (0.54) PPARAPPARDMRGPRX4HPGDNLRP1
SCHEMBL4336877 0.88 PPARA (0.55) PPARAPPARDMRGPRX4HPGDMAPT
SCHEMBL4335691 0.86 PPARA (0.54) PPARAPPARDMRGPRX4HPGDMAPT
SCHEMBL4341219 0.85 PPARA (0.53) PPARAPPARDMRGPRX4HPGDNLRP1
SCHEMBL4333274 0.84 PPARA (0.59) PPARAPPARDMRGPRX4HPGDNLRP1
SCHEMBL4340261 0.81 MRGPRX4 (0.53) PPARAPPARDMRGPRX4PPARGTDP1
SCHEMBL4327650 0.77 PPARA (0.51) PPARAPPARDMRGPRX4PPARGSMN1; SMN2
SCHEMBL4327910 0.77 PPARA (0.51) PPARAPPARDMRGPRX4PPARGSMN1; SMN2
SCHEMBL4327644 0.77 PPARA (0.51) PPARAPPARDMRGPRX4PPARGSMN1; SMN2
SCHEMBL31324842 0.77 PNMT (0.61) PPARAPPARGTSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7544835-B2 Carboxylic acid derivative and salt thereof EISAI R&D MANAGEMENT CO., LTD. (JP) 2009-06-09 US disclosed
US-7544835-B2 Carboxylic acid derivative and salt thereof EISAI R&D MANAGEMENT CO., LTD. (JP) 2009-06-09 US disclosed
US-7544835-B2 Carboxylic acid derivative and salt thereof EISAI R&D MANAGEMENT CO., LTD. (JP) 2009-06-09 US disclosed
US-20040102634-A1 Carboxylic acid derivative and salt thereof EISAI R&D MANAGEMENT CO., LTD. (JP) 2004-05-27 US disclosed
EP-1380562-A1 CARBOXYLIC ACID DERIVATIVE AND SALT THEREOF Eisai Co., Ltd. (JP) 2004-01-14 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040102634-A1 Carboxylic acid derivative and salt thereof GPR119, IRS1, SLC5A1 PPARA 339/4885PPARD 753/4885MRGPRX4 428/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.